A young adult female has severe cystic acne and is requesting treatment with Accutane (isotretinoin) after failing many therapies under your care. The appropriate response is to:

Acne vulgaris is a common inflammatory skin condition caused by follicular plugging, excess sebum production, Cutibacterium acnes proliferation, and inflammation. Treatment is based on severity, with mild acne typically managed using topical therapies that reduce bacterial load and prevent comedone formation. First-line management prioritizes safe, effective, and low-risk treatments before progressing to combination or systemic therapies. Over-the-counter options are commonly used as initial therapy for mild cases.

Rationale:
A. Topical retinoids are effective for acne because they normalize follicular keratinization and prevent comedone formation. However, they are often used as part of a broader treatment plan and may cause skin irritation, dryness, and photosensitivity. While useful, they are not always the simplest first-line monotherapy option for very mild acne compared to benzoyl peroxide alone.

B. Benzoyl peroxide and clindamycin (Benzaclin) is typically reserved for moderate acne or cases where bacterial inflammation is more pronounced. While effective, combination therapy with an antibiotic is not necessary for mild acne and may contribute to antibiotic resistance if overused. Therefore, it is not the preferred initial monotherapy for mild disease.

C. Minocycline (Minocin) is a systemic antibiotic used for moderate to severe inflammatory acne. It is not indicated for mild acne due to risks such as antibiotic resistance, gastrointestinal side effects, photosensitivity, and potential long-term adverse effects. Oral therapy is reserved for more extensive or refractory cases.

D. Over-the-counter benzoyl peroxide is the first-line treatment for mild acne because it effectively reduces Cutibacterium acnes and decreases inflammation without contributing to antibiotic resistance. It is safe, widely available, and well tolerated for initial management. This makes it the most appropriate starting therapy for mild acne presentations.

Plaque psoriasis is a chronic inflammatory skin disorder characterized by well-demarcated erythematous plaques with silvery scaling, resulting from rapid keratinocyte turnover and immune-mediated inflammation. Initial treatment is typically based on disease severity, with mild to moderate cases managed using topical therapies that reduce inflammation and control plaque formation. Corticosteroids are the mainstay of first-line therapy due to their strong anti-inflammatory effects and rapid symptom control when used appropriately.

Rationale:
A. Anthralin (Dritho-Creme) is effective for psoriasis by slowing keratinocyte proliferation, but it is not commonly used as initial therapy due to its irritant properties, staining of skin and clothing, and need for careful application. It is generally reserved for more resistant plaques or as an adjunct therapy rather than first-line treatment.

B. Pimecrolimus (Elidel) is primarily indicated for atopic dermatitis, especially in sensitive areas such as the face or intertriginous regions. It is not considered a first-line treatment for plaque psoriasis because it has limited efficacy on thick, scaly plaques found in typical psoriatic lesions.

C. Burow’s solution (aluminum acetate) wet soaks are used for soothing inflamed or weeping skin conditions, such as acute dermatitis or minor skin infections. While they may provide symptomatic relief, they do not address the underlying immune-mediated inflammation of plaque psoriasis and are not effective as primary treatment.

D. Triamcinolone 0.1% (Kenalog) is an appropriate initial treatment for plaque psoriasis because it effectively reduces inflammation, erythema, and scaling. Intermittent “pulse” therapy helps minimize side effects such as skin atrophy while maintaining disease control. Topical corticosteroids are considered first-line therapy for localized mild to moderate plaque psoriasis due to their efficacy and rapid symptom relief.